Rosesolute Cream 10 mg/g: Uses, Dosage & Side Effects

A prescription-only topical cream containing rosesolute 10 mg per gram (1%), prescribed by a licensed clinician for cutaneous treatment in adults. This evidence-based summary explains how to use it safely, what to expect, and when to contact your healthcare provider.

Prescription Only (Rx) Topical Cream ATC: Refer to SmPC
Active Ingredient
Rosesolute 10 mg/g (1%)
Dosage Form
Cream for cutaneous use
Strength
10 mg/g (1% w/w)
Brand Name
Rosesolute

Rosesolute is a prescription-only topical medicine supplied as a cream containing the active substance rosesolute at a concentration of 10 mg per gram (1% w/w). It is intended for application to the skin and must be prescribed by a licensed healthcare professional who has assessed your condition. Because Rosesolute is a regulated prescription medicine, the authoritative source of clinical information is the official Summary of Product Characteristics (SmPC) and the patient information leaflet that accompanies the product in your country. This page provides general, evidence-based guidance on how to use prescription topical creams safely and what questions to discuss with your doctor or pharmacist; it is not a substitute for the regulator-approved label or for individual medical advice.

Quick Facts: Rosesolute

Active Ingredient
Rosesolute
Drug Class
Topical Cream
Strength
10 mg/g (1%)
Dosage Form
Cream
Route
Cutaneous (Skin)
Prescription Status
Prescription Only (Rx)

Key Takeaways

  • Rosesolute 10 mg/g cream is a prescription-only topical medicine and must only be used under the direction of a licensed healthcare professional who has assessed your skin and overall medical situation.
  • Apply Rosesolute exactly as prescribed: a thin layer to the affected area only, at the prescribed frequency, for the duration your doctor has specified. Do not use more, more often, or for longer than directed.
  • Wash and dry the skin and your hands before application, gently rub the cream in until absorbed, and wash your hands afterwards unless your hands are themselves the area being treated.
  • Do not use Rosesolute if you are allergic to the active ingredient or any excipient listed in the patient information leaflet, on broken or infected skin without medical advice, or in or near the eyes, mouth, or other mucous membranes.
  • Discuss pregnancy, breastfeeding, other prescription or over-the-counter medicines, and any history of skin conditions or allergies with your prescriber before starting Rosesolute, and consult the official Summary of Product Characteristics for the regulator-approved indications, contraindications, and complete safety profile.

What Is Rosesolute and What Is It Used For?

Quick Answer: Rosesolute is a prescription-only cream containing 10 mg of the active substance rosesolute per gram (1%). It is applied to the skin to treat the condition for which your doctor has prescribed it. Because it is a prescription product, the regulator-approved indication, dosing, and patient eligibility are set out in the official Summary of Product Characteristics (SmPC) for your country and should always take precedence over general information.

Rosesolute is a topical pharmaceutical preparation formulated as a smooth, semi-solid cream that is intended for application to the skin. The product contains the active substance rosesolute at a concentration of 10 mg per gram, which corresponds to 1% by weight. Topical creams in this strength range are widely used in dermatology and primary care for a variety of cutaneous conditions, with the precise indication, mechanism of action, and patient-selection criteria determined by the active substance and the regulator-approved label. Because Rosesolute is supplied as a prescription-only medicine (POM), it can be obtained legally only on the basis of a valid prescription written by a licensed healthcare professional after appropriate clinical assessment.

The decision to prescribe a topical product is shaped by several considerations: the suspected or confirmed diagnosis, the location and extent of the affected skin, the patient's age, pregnancy status, history of allergies, concurrent medications, and any history of adverse reactions to similar products. A topical formulation is often chosen when treatment can be effectively delivered locally, with the goal of achieving a therapeutic concentration at the site of disease while minimizing systemic exposure. For some indications, a 1% cream provides a balance between adequate local delivery and a favourable tolerability profile compared with stronger preparations.

The cream base in which the active ingredient is dispersed is itself important. A cream is a semi-solid emulsion of oil and water, typically containing emulsifiers, preservatives, humectants, and water in proportions that determine spreadability, absorption rate, and skin feel. Compared with ointments (which are greasier and form an occlusive layer) and gels (which dry rapidly and are often alcohol-based), creams are generally well tolerated on most skin types, are easy to apply over moderate-sized areas, and leave little residue. The full list of excipients is printed in the patient information leaflet and on the carton, and is essential reading for anyone with known allergies to common topical ingredients.

The indication — the medical condition for which Rosesolute is officially licensed — is set out in the regulator-approved Summary of Product Characteristics (SmPC) issued by the medicines authority in your country (for example, the European Medicines Agency in the European Union, the Medicines and Healthcare products Regulatory Agency in the United Kingdom, the U.S. Food and Drug Administration in the United States, or equivalent national authorities elsewhere). Your prescribing doctor will have selected Rosesolute because they consider it the most appropriate option for your specific clinical situation, and they will have explained the expected benefit, the typical duration of treatment, and what to look for as evidence that the medicine is working.

Topical treatments differ fundamentally from oral medicines in their pharmacokinetic profile. When a cream is applied to intact skin, only a fraction of the active substance penetrates the stratum corneum (the outermost barrier layer of the skin) and reaches deeper tissues. The amount that crosses the skin barrier depends on the concentration in the formulation, the chemistry of the active substance, the integrity and hydration of the skin, the body site, the area of application, the duration of contact, and whether the area is occluded by clothing, dressings, or natural skin folds. A small proportion may eventually reach the systemic circulation, but for most topical products applied to limited areas, plasma concentrations remain well below those achieved by equivalent oral or injected doses. This profile is one reason topical therapy is preferred when the disease process is confined to the skin.

Because Rosesolute is dispensed only against a prescription, you should regard the dispensing pharmacist as a key partner in your treatment alongside the prescribing doctor. At collection, the pharmacist will normally confirm your understanding of how to apply the cream, how often, for how long, and what to do if a dose is missed or if a problem occurs. They can also advise on coordinating Rosesolute with any moisturisers, sunscreens, makeup, or other topical products you currently use. Keep the patient information leaflet that comes with the carton, and read it before your first application; it contains the most accurate, up-to-date, and product-specific information for your particular pack.

What Should You Know Before Using Rosesolute?

Quick Answer: Before starting Rosesolute, your doctor and pharmacist need to know about any allergies, current medicines (including over-the-counter products and herbal remedies), pregnancy or plans to become pregnant, breastfeeding, other skin conditions, and any previous reactions to topical creams. Do not use Rosesolute on broken, infected, or irritated skin, or near the eyes or mucous membranes, unless your doctor has specifically advised it.

Before applying the first dose of Rosesolute, take a few minutes to read the patient information leaflet supplied with the cream and confirm that you understand the prescriber's instructions. Prescription topical creams are safe and effective when used correctly, but their benefits depend on selecting the right patient, the right area, the right amount, and the right duration of treatment. The points below cover the most important questions to discuss with your doctor or pharmacist before you start, organised into contraindications, warnings and precautions, and special populations such as pregnant or breastfeeding women, children, and older adults.

Contraindications

A contraindication is a situation in which a medicine should not be used because the risks clearly outweigh the benefits. The full and authoritative list of contraindications for Rosesolute is set out in the official Summary of Product Characteristics. As a general framework for prescription topical creams, you should not use Rosesolute if any of the following apply, unless your doctor has specifically advised otherwise:

  • Hypersensitivity (allergy) to the active substance rosesolute or to any of the excipients listed in the patient information leaflet. Allergic reactions to topical products can range from mild itching and redness to severe contact dermatitis and, very rarely, systemic reactions such as urticaria or anaphylaxis.
  • Application to broken, infected, ulcerated, or freshly traumatised skin without medical advice. Damaged skin allows greatly increased absorption and can also concentrate active substance and excipients in deeper tissues, leading to greater local irritation or unintended systemic exposure.
  • Use on or in the immediate vicinity of the eyes, eyelids, mouth, lips, nose, or genital mucosa, unless the prescriber has specifically directed and shown you how to do so safely. Mucous membranes absorb topical actives much more readily than intact skin and are particularly susceptible to chemical irritation.
  • Application to a different skin condition than the one for which Rosesolute was prescribed, even if the new problem looks similar. The differential diagnosis of skin disease is complex, and using an inappropriate topical product can mask a diagnosis, allow an infection to spread, or worsen an underlying disease.
  • Use in any patient or situation explicitly listed as a contraindication in the SmPC for your country, including (where applicable) specific age limits, certain comorbidities, or particular concomitant medications.

If you are not sure whether any of these apply to you, do not start treatment until you have discussed the question with your prescriber or pharmacist. It is often safer to delay the first application by a day to clarify a doubt than to apply a cream and then discover that it should not have been used.

Warnings and Precautions

For External Use Only

Rosesolute cream is intended exclusively for application to the skin. Do not swallow the cream and do not allow it to come into contact with the eyes, mouth, or other mucous membranes. If accidental ingestion occurs — particularly in a child — contact your local poison control centre or emergency services immediately, even if no symptoms have appeared. If the cream gets into the eyes, rinse them with plenty of clean lukewarm water for at least 10 minutes and seek medical advice if irritation persists.

Even when there is no formal contraindication, certain situations call for additional caution. Tell your doctor and pharmacist about all of the following before starting Rosesolute:

  • Any previous allergic reactions to topical medicines, cosmetics, fragrances, sticking plasters, hair dyes, or rubber products. A history of contact allergy increases the likelihood of reacting to a new topical product, and may guide the prescriber to choose a different formulation or to recommend a small test application before more widespread use.
  • Any chronic skin conditions such as eczema (atopic dermatitis), psoriasis, rosacea, seborrhoeic dermatitis, or recurrent skin infections. These conditions can change skin barrier function and modify the way a topical cream is absorbed and tolerated.
  • Any open wounds, recent surgical scars, sunburn, or skin infections on or near the area to be treated. These should be allowed to heal first, or the prescriber may select a different application site.
  • All other medicines and topical products you currently use, including prescription medicines, over-the-counter products, herbal remedies, vitamin or mineral supplements, and skin-care products such as moisturisers, sunscreens, retinoids, or exfoliating cleansers.
  • Plans to undergo any cosmetic, dermatological, or surgical procedure on the area of skin where Rosesolute will be applied.
  • Conditions that affect the immune system or any chronic illness for which you receive treatment, since some topical medicines should be used with extra caution in immunocompromised patients.

During treatment, follow some general principles to maximise safety and effectiveness. Apply the cream only to the area of skin specified by your doctor; do not extend treatment to surrounding skin in the hope of preventing the condition spreading. Use the smallest amount that produces an even, thin film over the affected area; more is not better. Keep the tube tightly closed when not in use to maintain hygiene and stability of the formulation. Do not transfer the cream to another container, as this can lead to contamination and loss of potency. Do not use the cream after the expiry date printed on the carton.

Some prescription topical creams should not be combined with strong sunlight or ultraviolet (UV) exposure of the treated area. If your prescriber has not given specific guidance, it is sensible to use sun protection on the treated area while you are using Rosesolute, particularly during peak UV months. Tanning beds and sun lamps should generally be avoided during treatment unless your doctor has advised otherwise. Discuss outdoor work, sport, and holidays in sunny climates with your prescriber if your treatment area is regularly exposed to sunlight.

When to Contact Your Doctor

Contact your prescriber promptly if you experience worsening of the original skin problem, new or unexpected symptoms beyond the treated area, signs of infection (warmth, increasing redness, pus, fever), or significant skin reactions such as severe burning, blistering, peeling, or widespread rash. Do not wait for a routine appointment if symptoms are severe or rapidly progressive.

Pregnancy and Breastfeeding

If you are pregnant, planning to become pregnant, or breastfeeding, tell your doctor before starting Rosesolute. The use of any prescription medicine in pregnancy involves balancing the expected benefit against any potential risk to the developing fetus, and this balance can change between trimesters and depending on the area and amount of skin involved. The Summary of Product Characteristics for Rosesolute will state the regulator-approved guidance for pregnancy use, which may range from "should not be used" to "use only when clearly necessary, after careful evaluation of benefit and risk."

For topical creams, systemic exposure is usually much lower than with oral or injected medicines, but absorption is not negligible — particularly when treatment involves large areas, prolonged use, or application under occlusive dressings or in skin folds. Even small amounts of an active substance reaching the maternal circulation can in principle cross the placenta or pass into breast milk. The decision to start, continue, or stop Rosesolute during pregnancy or lactation should always be made in consultation with the prescribing doctor, weighing the importance of treating the underlying condition against the goal of minimising fetal or infant exposure.

If you are breastfeeding, do not apply Rosesolute to the breast or anywhere the baby's skin or mouth could come into direct contact with the cream during feeding or cuddling. Wash your hands thoroughly after each application before handling your baby. If a treatment area is unavoidably close to areas of skin contact, discuss alternative options with your doctor. Inform your obstetrician, midwife, paediatrician, or health visitor that you are using Rosesolute, so that any decision affecting mother or baby (such as routine immunisations or other treatments) can be made with full information.

Use in Children and Older Adults

The use of Rosesolute in children and adolescents requires specific medical advice. Children's skin differs from adult skin in several important respects: the stratum corneum is thinner, the surface area is much larger relative to body weight, and skin barrier function may be less mature. As a result, percutaneous absorption of topical actives is generally higher in young children than in adults, which can change the benefit-risk balance. Whether Rosesolute is suitable for a particular child depends on the child's age, the indication, the area to be treated, and the regulator-approved labelling. Do not apply an adult prescription to a child without explicit paediatric instructions.

For older adults (typically defined as 65 years and over), no specific dose adjustment is usually required for topical creams, but several factors can shift the balance of benefit and risk. Older skin tends to be thinner, drier, and more fragile, which can increase the risk of irritation and the absorption of topical actives. Older patients are also more likely to have several concurrent medical conditions, take multiple medications, and have reduced kidney or liver function, all of which can interact with even small amounts of systemically absorbed topical drug. A short trial on a limited area at the start of treatment can help assess tolerance before continuing or extending therapy.

Driving and Operating Machinery

Topical creams applied to limited areas of skin do not normally affect alertness, reaction time, or coordination, and Rosesolute is not generally expected to impair the ability to drive or operate machinery. If, however, you experience any unusual symptoms during treatment — such as dizziness, blurred vision (for example, after accidental contact of the cream with the eyes), or marked sedation — do not drive or use machinery until the symptoms have resolved and you have spoken to a healthcare professional. Always check the patient information leaflet for the specific guidance issued by the manufacturer.

How Does Rosesolute Interact with Other Drugs?

Quick Answer: Because Rosesolute is applied to the skin, the most clinically important interactions are typically with other topical products applied to the same area, rather than with oral medications. However, you should still tell your doctor and pharmacist about every medicine you take — prescription, over-the-counter, herbal, or supplement — because the official Summary of Product Characteristics may identify systemic interactions that need to be considered.

Topical medicines applied to limited areas of skin generally produce low systemic exposure, which means that interactions with oral, injected, or inhaled medicines are usually less prominent than for systemic therapies. Nevertheless, three categories of interaction deserve attention for any prescription topical cream: interactions at the application site (with other topical products), pharmacodynamic interactions resulting from the small amount of active substance that reaches the systemic circulation, and pharmacokinetic interactions in patients who use the cream over large areas, on damaged skin, or under occlusive dressings.

Always present your complete and current medication list at every consultation and at every visit to the pharmacy. The list should include prescription medicines, over-the-counter products such as analgesics or antihistamines, dietary supplements, herbal remedies, and topical products such as steroid creams, antibiotic ointments, retinoids, scrub formulations, and cosmetic products. Several pharmacy chains and electronic health records provide free medication-reconciliation services that can help you produce an up-to-date list before your appointment.

Notable Interaction Categories

Notable Interaction Categories with Rosesolute Cream
Interacting Category Effect Clinical Advice
Other topical products on the same skin area Layering creams, ointments, gels, or lotions on the same area can change the absorption of Rosesolute, dilute its action, increase irritation, or trigger contact reactions to combinations that would otherwise be tolerated Apply Rosesolute alone unless your doctor has explicitly authorised a combination. If a moisturiser or sunscreen is also needed, separate the applications by at least 15–30 minutes and apply Rosesolute first unless directed otherwise.
Topical corticosteroids Concurrent topical steroid use on the same area may modify local immune and inflammatory responses, potentially affecting both the efficacy of Rosesolute and the risk of skin atrophy or other steroid effects Combine only on medical advice; if both products are prescribed, follow the specific timing and sequence the prescriber has recommended.
Cosmetics, perfumes, fragranced lotions Fragrances and many cosmetic ingredients are well-recognised causes of contact dermatitis; combining them with a prescription cream on the same skin can intensify reactions and complicate the assessment of side effects Avoid perfumes, scented lotions, and unfamiliar cosmetics on the treated area during therapy.
Other systemically active medicines Although systemic exposure to most topical creams is low, very extensive or prolonged use can produce measurable plasma concentrations capable of interacting with oral medications listed in the SmPC Provide a complete medication list at every consultation. Ask your prescriber whether any of your current medicines are mentioned in the Rosesolute SmPC and whether any monitoring is recommended.
Alcohol-based skin products Alcohol-based cleansers, toners, or hand sanitisers can increase skin permeability and disturb the skin barrier, potentially altering absorption and increasing irritation Allow the skin to fully dry after using alcohol-based products before applying Rosesolute, or use a non-alcohol cleanser on the treated area.

Practical Steps to Reduce Interaction Risk

Some simple practical steps can substantially reduce the risk of interactions during topical therapy. First, always confirm with your pharmacist when you collect a new prescription that they have screened your full record for interactions with Rosesolute and that no concerning combinations are present. Second, when starting a new medication of any kind, tell the prescriber that you are using Rosesolute on the skin, even if the new medicine is for an unrelated problem. Third, if you visit a different doctor (for example, a hospital specialist, an emergency department clinician, or a travel-medicine doctor), include Rosesolute on the medication list you provide.

Be especially careful with over-the-counter topical products, including antiseptic creams, antibiotic ointments, anti-fungal preparations, anti-itch creams (such as those containing crotamiton or pramoxine), and traditional remedies. These are widely available and can seem harmless, but they may interact with Rosesolute on the skin in ways that are not always obvious. If in doubt, ask the pharmacist before purchasing.

Topical Co-Application

Do not layer Rosesolute on top of other topical medications (such as topical corticosteroid creams, antibiotic ointments, or counterirritant rubs) at the same site unless your prescriber has specifically advised it. Layering can unpredictably change absorption, potentially producing either reduced efficacy or increased side effects.

What Is the Correct Dosage of Rosesolute?

Quick Answer: Always follow the exact instructions of your prescribing doctor and the patient information leaflet supplied with your specific Rosesolute pack. As a general principle, prescription topical creams at 10 mg/g (1%) are applied as a thin layer to the affected area only, typically once or twice daily. Do not apply more cream than prescribed, do not apply more often than directed, and do not continue treatment beyond the duration your doctor has set without re-assessment.

The "dose" of a topical cream is determined by three variables: the amount of cream applied each time, the frequency of application, and the duration of the treatment course. The prescriber sets all three of these based on the indication, the location and extent of the skin involved, the patient's age and overall health, and the regulator-approved label. Because Rosesolute is a prescription product, the precise dosing for your situation will be specified by your doctor — typically in writing on the prescription, in the dispensing label on the pharmacy package, and in the patient information leaflet inside the carton.

The information below describes the general principles that apply to most prescription topical creams of this strength, including practical advice on application technique, fingertip-unit dosing, missed doses, and what to do in the rare event of accidental ingestion or overdose. It does not replace the specific instructions you have been given for your prescription.

Adults

General Adult Dosing for Rosesolute 10 mg/g Cream

Single application: Apply a thin film of cream to the affected area only, using just enough to cover the skin without leaving a thick or uneven layer.

Frequency: Apply at the frequency prescribed by your doctor (commonly once or twice daily for prescription topical creams). Do not apply more often than instructed in an attempt to speed up the response.

Duration: Use for the full course your doctor has prescribed, even if your symptoms improve before the course is complete. If symptoms have not improved after the expected interval, contact the prescriber for review rather than extending treatment yourself.

Source of authoritative dosing: The exact dosing schedule for your prescription is the one specified by your doctor and printed on the dispensing label and patient information leaflet.

Step-by-Step Application Method

Correct application is essential for both safety and effectiveness. The following steps apply to most prescription creams; adjust them as your prescriber has specifically instructed.

  1. Wash your hands with soap and warm water, then dry them on a clean towel. Wash and dry the affected skin area as well, unless the leaflet says otherwise. Clean, dry skin allows even application and reduces the risk of introducing bacteria.
  2. Inspect the skin at the application site. If you notice new cuts, infection, severe redness, or unexpected changes since your last application, contact your prescriber before continuing.
  3. Squeeze a small quantity of cream onto a clean fingertip. The "fingertip unit" (FTU) — the amount of cream squeezed from a standard 5 mm nozzle along the length of an adult index finger from the tip to the first crease — is a useful reference for many topical preparations and corresponds to roughly 0.5 g of cream, sufficient to cover an area about the size of two adult palms.
  4. Apply a thin layer to the affected area only, spreading the cream evenly with a clean fingertip until it is barely visible. Do not extend the application beyond the affected skin.
  5. Gently rub the cream into the skin until it is mostly absorbed. If the cream remains visible after several minutes, you may have applied too much; wipe off the excess with a clean tissue.
  6. Do not cover the area with airtight dressings, plastic wrap, or tight clothing immediately after application unless your doctor has specifically told you to. Occlusion increases absorption and can cause irritation.
  7. Wash your hands thoroughly with soap and water after each application, unless your hands are themselves the area being treated. This prevents accidentally transferring the cream to your eyes, mouth, food, or other people.
  8. Replace the cap securely on the tube and store as directed on the packaging.

Children and Adolescents

The use of Rosesolute in children and adolescents depends on the regulator-approved labelling and the prescriber's clinical judgement. Children should never receive a topical prescription unless the prescription has been specifically written for them, with dosing and area of application defined for their age, weight, and clinical situation. Because percutaneous absorption is generally higher in children, the smallest effective amount is preferred, and short trial periods may be appropriate at the start of treatment. Parents and caregivers should keep all prescription medicines, including Rosesolute, securely out of children's reach.

Elderly Patients (65 Years and Older)

For most older adults, no specific dose adjustment of topical creams is required, but several factors warrant additional vigilance. Older skin tends to be drier and thinner, which can increase the risk of irritation, and reduced kidney or liver function may affect the small amount of active substance that reaches the systemic circulation through extensive or prolonged use. A short initial trial on a limited area helps assess tolerance, and regular review with the prescriber is recommended for chronic use. Older patients are also more likely to take multiple medications, so an updated medication review at the start of any new therapy is particularly valuable.

Hepatic and Renal Impairment

For patients with mild to moderate liver or kidney impairment, no formal dose adjustment is generally specified for topical creams used as directed on limited areas. However, reduced organ function can prolong elimination of any active substance that does reach the systemic circulation, so these patients should use the smallest amount for the shortest effective duration and stay within the prescribed area. Patients with severe liver or kidney disease should consult the prescriber, who may opt for additional monitoring or an alternative formulation.

Missed Dose

If you forget to apply Rosesolute, apply it as soon as you remember on the same day. If it is almost time for your next scheduled application, skip the missed dose and continue with your usual schedule. Do not apply a double quantity of cream to make up for a missed dose, because applying more cream at one time does not increase the benefit and may increase the risk of skin irritation or systemic absorption. Try to apply the cream at the same times each day to support consistent absorption and to reduce the likelihood of forgetting a dose.

Overdose and Accidental Ingestion

Overdose of a topical cream applied as directed is rare, because the surface area and duration are inherently limited. The most likely overdose scenarios are: applying very large amounts of cream over extensive areas of skin for prolonged periods, applying the cream under occlusive dressings, applying to areas of broken or inflamed skin (which dramatically increases absorption), or accidental oral ingestion — particularly in young children who may sample the cream from a tube left within reach.

If you have applied much more cream than prescribed in a single application, gently wipe off the excess with a clean dry tissue (do not vigorously scrub the skin), wash the area with mild soap and lukewarm water, and pat dry. Observe the treated area and your general condition for any unusual symptoms. If you develop unexpected symptoms — such as severe local irritation, widespread rash, dizziness, nausea, or any systemic complaint — contact your prescriber, your pharmacist, or your local emergency services for advice. Always store Rosesolute, like all medicines, securely out of the sight and reach of children and pets.

What Are the Side Effects of Rosesolute?

Quick Answer: Like all medicines, Rosesolute can cause side effects, although not everyone will experience them. The most commonly expected reactions to prescription topical creams are local skin effects at the application site, including redness, mild burning or stinging, itching, dryness, or irritation; these are usually mild and improve after dose adjustment or discontinuation. Serious systemic effects are uncommon when the cream is used as directed. Always consult the patient information leaflet for the complete and product-specific list of adverse reactions for your particular pack.

Because Rosesolute is applied to the skin, the side-effect profile of a prescription topical cream of this strength is dominated by local cutaneous reactions at and around the application site. Systemic effects similar to those of oral medicines are possible — particularly with very extensive use, prolonged application, or use on damaged skin — but are far less common than local reactions. The list below presents reactions according to general frequency categories used in patient information leaflets across most regulatory regions. The complete and product-specific list of adverse reactions for Rosesolute, including any reactions reported during clinical trials and post-marketing surveillance, is set out in the patient information leaflet supplied with your pack.

Common

May affect up to 1 in 10 people
  • Skin redness (erythema): Pink or red discoloration at or near the application site
  • Mild burning or stinging: Particularly in the first few minutes after application; usually self-limiting
  • Itching (pruritus): Localised itching on or around the treated skin
  • Dryness or peeling: Mild scaling or flaking with continued use
  • Mild contact dermatitis: Inflammation of the skin in the area of application

Uncommon

May affect up to 1 in 100 people
  • Localised swelling (oedema): Mild puffiness at the treated site
  • Hyperpigmentation or hypopigmentation: Temporary darkening or lightening of the treated skin, more noticeable in deeper skin tones
  • Worsened or paradoxical irritation: Increase in local discomfort that does not settle after dose adjustment
  • Folliculitis: Inflammation of hair follicles in the treated area
  • Skin sensitivity to sunlight: A tendency to burn or react more easily to UV exposure on the treated area

Rare

May affect up to 1 in 1,000 people
  • Allergic contact dermatitis: Delayed hypersensitivity reaction with intense redness, swelling, itching, and sometimes blistering
  • Skin atrophy: Thinning of the skin with prolonged or repeated use, especially on delicate areas
  • Telangiectasia: Visible small blood vessels at the surface of the treated skin
  • Striae (stretch marks): Particularly with extensive use in skin-fold areas
  • Secondary skin infection: Bacterial, viral, or fungal superinfection of the treated area

Very Rare

May affect fewer than 1 in 10,000 people
  • Severe cutaneous reactions: Including erythema multiforme and, in isolated cases, more severe blistering reactions requiring specialist care
  • Angioedema: Sudden swelling of the face, lips, tongue, or throat requiring immediate medical evaluation
  • Anaphylaxis: Severe systemic allergic reaction with hypotension and respiratory compromise
  • Systemic symptoms from extensive prolonged use: Symptoms attributable to systemic absorption of the active substance, as detailed in the SmPC
Skin Reactions Are the Most Common Reason for Discontinuation

In clinical use, the great majority of side effects from prescription topical creams are local skin reactions rather than systemic symptoms. Many mild reactions resolve on their own within 24–48 hours of discontinuation. If redness or itching persists for more than 48 hours after stopping the cream, if blistering or severe pain develops, or if the skin appears burned, ulcerated, or infected, contact your healthcare professional promptly.

Some factors increase the risk of local reactions and should be considered when using Rosesolute. These include: applying the cream to highly sensitive skin areas (face, eyelids, neck, inner thighs, genital area); applying to broken or freshly shaved skin; using the cream more frequently or in larger amounts than prescribed; covering the treated area with airtight dressings or tight clothing; concurrent use of other topical products on the same area; exposure of the treated skin to sunlight, UV tanning beds, hot water, or saunas; and pre-existing skin conditions such as atopic dermatitis or rosacea.

If you experience any unexpected symptoms while using Rosesolute — even symptoms not listed here — discontinue use and consult a healthcare professional. You can also report suspected side effects to your national pharmacovigilance authority (for example, the U.S. FDA MedWatch program, the UK MHRA Yellow Card scheme, Health Canada's MedEffect program, or the European Medicines Agency's EudraVigilance system). Reporting adverse events helps regulators monitor medication safety and update guidance when needed.

How Should You Store Rosesolute?

Quick Answer: Store Rosesolute according to the storage conditions printed on the carton and tube — typically at room temperature (often below 25 to 30°C), away from direct sunlight, heat, and humidity. Keep the tube tightly closed and out of the reach of children and pets. Do not use after the expiry date, and return unused medicine to a pharmacy for safe disposal.

Proper storage of Rosesolute helps preserve both the potency of the active ingredient and the physical and microbiological quality of the cream. Always follow the specific storage instructions printed on the carton, the tube label, and the patient information leaflet supplied with your particular pack, as they take precedence over general guidance. Storage conditions can vary slightly between manufacturing batches and between countries.

  • Temperature: Most prescription creams should be stored at controlled room temperature, generally below 25 to 30°C (77 to 86°F), unless the leaflet specifies a different range or refrigeration. Avoid storing the cream in places that can become very hot, such as a hot car, a sunlit windowsill, or near a radiator or stove. Heat can degrade the active substance and alter the consistency of the emulsion.
  • Humidity: Avoid high-humidity environments such as bathrooms or damp cupboards, as humidity can affect both the cream itself and the integrity of the carton and leaflet. A bedroom drawer or kitchen cabinet away from the sink is usually a better choice.
  • Light: Protect the tube from prolonged exposure to direct sunlight. Keeping the cream in its original carton between uses provides additional protection from light.
  • Container: Keep the tube tightly closed when not in use. Loose caps allow contamination and water loss, which can change the consistency of the cream and reduce its useful life.
  • Hygiene: Avoid touching the nozzle or opening of the tube with your fingers or with the affected skin. Squeeze the cream onto a clean fingertip rather than applying directly from the tube to the skin.
  • Child and pet safety: Store all medicines, including Rosesolute, securely out of the sight and reach of children and pets. Even small amounts of an inappropriately ingested topical medicine can be harmful to a young child.
  • Expiry date: Do not use Rosesolute after the expiry date printed on the carton and tube (usually shown as "EXP" followed by a month and year). The expiry date refers to the last day of the month shown.
  • After-opening shelf life: Some creams have a shorter "in-use" stability after the tube has been opened, indicated by a small symbol of an open jar on the carton (for example, "6M" meaning six months after opening). Note the date you first open the tube on the carton if your prescriber recommends doing so.
  • Disposal: Do not throw unused or expired medicines into household waste or pour them down the sink or toilet. Return unused or expired Rosesolute to a pharmacy that participates in a medicine take-back scheme. Pharmacists can advise on local disposal arrangements.

If at any point you notice that the cream has changed in appearance — for example, the colour or smell has changed, the texture has become grainy, separated, or unusually liquid, or the tube appears damaged — do not use the product. Take the tube and carton to your pharmacist for advice. Quality issues with prescription medicines should be reported to the supplying pharmacy and to your national medicines regulator.

What Does Rosesolute Contain?

Quick Answer: Each gram of Rosesolute cream contains 10 mg of the active substance rosesolute (1% w/w), together with the inactive ingredients (excipients) needed to form a stable, skin-friendly cream. The complete and authoritative list of excipients is printed in the patient information leaflet supplied with your pack and is essential reading for anyone with known allergies to common topical ingredients.

Understanding what is in your medicine helps you use it safely, anticipate any interactions or sensitivities, and make informed choices about other products you apply to the same skin. Pharmaceutical creams are formulated as oil-in-water or water-in-oil emulsions and contain not only the active substance but also a number of excipients chosen to make the product stable, easy to apply, and well-tolerated by the skin.

Active Ingredient

  • Rosesolute 10 mg/g (1% w/w) — the active pharmaceutical ingredient that produces the intended therapeutic effect. The pharmaceutical-grade material is manufactured to defined purity, particle-size, and stability specifications set out in the regulatory dossier for the product.

Typical Excipients in a 1% Topical Cream

The exact excipients used in Rosesolute are listed in the patient information leaflet for your pack. As a general framework, prescription creams of this strength typically contain a combination of the following categories of inactive ingredients:

  • Water (purified water): The primary solvent and a major component of the aqueous phase of the cream.
  • Emollients and oils: Such as liquid paraffin, white soft paraffin, isopropyl myristate, or vegetable-derived oils, providing the lipid phase of the emulsion and contributing to skin softness and emolliency.
  • Emulsifiers and stabilisers: Such as cetostearyl alcohol, glyceryl monostearate, polysorbate, or sorbitan ester, which keep the oil and water phases dispersed in a stable emulsion.
  • Humectants: Such as glycerol (glycerin) or propylene glycol, which retain water and reduce skin dehydration.
  • Preservatives: Such as parabens, benzyl alcohol, or sorbic acid, which prevent microbial growth in the aqueous phase. These can occasionally cause contact reactions in sensitive individuals.
  • pH adjusters and buffers: Such as citric acid or sodium hydroxide, used in small amounts to maintain the cream within a skin-compatible pH range.
  • Antioxidants: Such as butylated hydroxytoluene (BHT) or tocopherol, used to protect oil-soluble ingredients from oxidation.
Excipient Allergies and Sensitivities

Some excipients commonly used in topical creams — particularly fragrances, certain preservatives, propylene glycol, and lanolin derivatives — are recognised causes of contact allergy. If you have a known allergy to any topical product or to a specific cosmetic ingredient, check the complete excipient list in the patient information leaflet for your Rosesolute pack before first use, and discuss any concerns with your pharmacist or doctor. Patients with a confirmed propylene glycol or paraben allergy, for example, may need an alternative formulation.

Appearance and Packaging

Rosesolute 10 mg/g cream is supplied as a smooth, semi-solid cream packed in a sealed metal or plastic tube fitted with a screw cap, contained within a printed cardboard carton along with the patient information leaflet. The exact pack sizes available may vary by country and prescription. Always check the carton for the manufacture date, expiry date, and batch (lot) number before use, and retain the packaging until your treatment course is complete in case any safety information needs to be referenced later. If you have any concerns about pack quality or labelling, raise them with your pharmacist before first use.

If you have known allergies to any component of Rosesolute, or if you develop a reaction during use, retain the carton and tube to share with your healthcare provider. The full ingredient list printed on the carton and in the leaflet is the most reliable reference, since formulations can be updated between batches and between markets. Reporting suspected allergic reactions to your national pharmacovigilance authority helps regulators monitor product safety.

Frequently Asked Questions About Rosesolute

No. Rosesolute 10 mg/g cream is a prescription-only medicine (POM/Rx) and must be obtained through a licensed healthcare professional. The prescriber will assess whether the medicine is appropriate for your skin condition, medical history, and current medications, and will provide individualized instructions. Self-medication without medical supervision is not appropriate for prescription topical products because incorrect use, prolonged application, or use on the wrong skin condition can result in lack of benefit, side effects, or worsening of the underlying problem. Always present a valid prescription at a licensed pharmacy and follow the dispensing pharmacist's counselling.

Apply Rosesolute cream exactly as your doctor or pharmacist has instructed. As a general principle for prescription topical creams at this strength, the steps are: wash and dry your hands and the affected area thoroughly, take a small quantity of cream onto a clean fingertip (commonly measured in fingertip units), spread a thin layer evenly over the affected skin area only, and gently rub it in until absorbed. Wash your hands afterwards unless your hands are themselves the area being treated. Do not apply more cream than prescribed in the belief it will work faster, do not cover the area with airtight dressings unless instructed, and do not share your prescription with anyone else, even if they appear to have the same skin problem.

If you forget to apply Rosesolute, apply it as soon as you remember on the same day. If it is almost time for your next scheduled application, skip the missed dose and continue with your usual schedule. Do not apply a double quantity to make up for a missed dose, because applying more cream at one time does not increase the benefit and may increase the risk of skin irritation or systemic absorption. Try to apply your cream at the same times each day, as consistent application is generally more important than perfect timing for topical treatments. If you are unsure, contact your prescriber or pharmacist for advice tailored to your specific treatment plan.

The use of Rosesolute during pregnancy and breastfeeding should be discussed with your doctor before starting or continuing treatment. Many topical medicines are absorbed through the skin to varying degrees, and even small amounts may reach the developing fetus or pass into breast milk. Your doctor will weigh the expected benefit of treatment against any potential risk based on the official Summary of Product Characteristics, your individual situation, the area and amount of skin to be treated, and the available alternatives. Do not start, stop, or change the dose of Rosesolute during pregnancy or breastfeeding without medical advice. If you become pregnant unexpectedly during treatment, contact your prescriber promptly. If you are breastfeeding, do not apply the cream to the breast or anywhere your baby's skin or mouth could come into direct contact.

Like all medicines, Rosesolute can cause side effects, although not everyone will experience them. The most commonly expected reactions to prescription topical creams are local skin effects at the application site, including redness, mild burning or stinging, itching, dryness, or irritation; these are usually mild and improve with continued use or after discontinuation. Less common but possible reactions include contact dermatitis, increased skin sensitivity, hyperpigmentation or hypopigmentation, and allergic reactions to the active ingredient or excipients. Serious systemic side effects from topical treatment are uncommon when the cream is used as directed on small areas. Always consult the patient information leaflet for the complete and product-specific list of adverse reactions, and contact your doctor promptly if you develop severe redness, blistering, swelling, breathing difficulties, or signs of an allergic reaction.

Store Rosesolute cream according to the storage conditions printed on the carton and tube. Most prescription creams should be kept at room temperature (typically below 25 to 30°C), away from direct sunlight and excessive heat or humidity. Keep the tube tightly closed when not in use to prevent contamination and water loss, which can change the consistency or stability of the cream. Always keep medicines out of the sight and reach of children, ideally in a locked cabinet. Do not use the cream after the expiry date printed on the packaging, and follow your local pharmacy's recommendations for safely returning unused or expired medicines for disposal rather than throwing them in household waste or pouring them down the sink.

Avoid applying other topical products to the same skin area as Rosesolute unless your doctor has specifically advised it. Combining different creams, ointments, sunscreens, perfumes, or cosmetic products on the same area can change how Rosesolute is absorbed, may dilute its effect, increase irritation, or trigger contact reactions to combinations that would otherwise be tolerated. If you also use moisturisers or sunscreens on the same area, separate the applications by at least 15 to 30 minutes, applying Rosesolute first unless your prescriber instructs otherwise. Tell your doctor and pharmacist about every prescription medicine, over-the-counter product, herbal remedy, and skin-care preparation you currently use, as some combinations are contraindicated.

References

This article is based on current international medical guidelines, regulatory documents, and peer-reviewed research on the safe use of prescription topical medicines. All sources meet evidence level 1A standards. Product-specific clinical information for Rosesolute is contained in the regulator-approved Summary of Product Characteristics and patient information leaflet supplied with your pack.

  1. European Medicines Agency (EMA). Guideline on the Clinical Investigation of Medicinal Products for Topical Use. Committee for Medicinal Products for Human Use (CHMP); 2023. Reference framework for the clinical evaluation of topical medicines in the European Union.
  2. Joint Formulary Committee. British National Formulary (BNF) — Topical Preparations: Principles of Use and Excipient Sensitivity. London: BMJ Group and Pharmaceutical Press; 2024. Evidence-based prescribing reference covering topical formulations, excipients, and patient counselling.
  3. World Health Organization (WHO). WHO Guidelines on Safe Prescribing and Patient Counselling. Geneva: WHO; 2022. Global guidance on the prescribing, dispensing, and counselling of regulated medicines, including topical preparations.
  4. U.S. Food and Drug Administration (FDA). Guidance for Industry: Topical Dermatologic Drug Products — In Vivo Bioequivalence and Labeling. FDA Center for Drug Evaluation and Research; 2022. Reference for the regulatory standards governing topical drug products in the United States.
  5. Long CC, Finlay AY. The finger-tip unit — a new practical measure. Clinical and Experimental Dermatology. 1991;16(6):444-447. doi:10.1111/j.1365-2230.1991.tb01232.x. Original description of the fingertip unit method now used internationally for dosing topical preparations.
  6. Surber C, Smith EW. The Mystical Effects of Dermatological Vehicles. Dermatology. 2005;210(2):157-168. doi:10.1159/000082574. Review of the role of vehicle and excipient choice in the efficacy and tolerability of topical formulations.
  7. Wahlberg JE, Lindberg M. Patch Testing in the Diagnosis of Contact Dermatitis. Contact Dermatitis (Frosch P, Menné T, Lepoittevin J-P, eds). Berlin: Springer; 2006. Foundational reference on contact allergy and excipient sensitivity in topical preparations.
  8. Medicines and Healthcare products Regulatory Agency (MHRA). Yellow Card Scheme: Reporting Suspected Adverse Drug Reactions. London: MHRA; 2024. Pharmacovigilance reporting framework used in the United Kingdom.
  9. European Medicines Agency (EMA). EudraVigilance: System for Pharmacovigilance Data Processing. EMA; 2024. EU pharmacovigilance database for spontaneous adverse reaction reports relating to medicines authorised in the European Economic Area.
  10. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH Harmonised Guideline E2A: Clinical Safety Data Management — Definitions and Standards for Expedited Reporting. ICH; updated 2024. Standard definitions of adverse drug reactions and reporting requirements used worldwide.
  11. World Health Organization (WHO). The Anatomical Therapeutic Chemical (ATC) Classification System. Geneva: WHO Collaborating Centre for Drug Statistics Methodology; 2024. International classification used to categorise active substances by anatomical site of action and therapeutic indication.
  12. National Institute for Health and Care Excellence (NICE). Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes (NG5). London: NICE; updated 2023. Best-practice guidance on prescribing, dispensing, and patient self-management of prescribed medicines.

Editorial Team

This article has been written and reviewed by the iMedic medical editorial team according to our strict editorial standards. Our team consists of licensed physicians, pharmacists, and medical researchers with expertise in clinical pharmacology, dermatology, and the safe use of prescription medicines.

Medical Writing

Content developed by iMedic's medical writing team based on current international guidelines (EMA, FDA, WHO, BNF, NICE) and peer-reviewed research on prescription topical medicines and patient counselling.

Medical Review

Independently reviewed and fact-checked by the iMedic Medical Review Board, comprising board-certified specialists in clinical pharmacology, dermatology, and primary care.

Evidence Standards

All medical claims are supported by Level 1A evidence (systematic reviews, meta-analyses, and randomized controlled trials) and by regulator-approved guidance, following the GRADE evidence framework.

Independence

iMedic receives no commercial funding from pharmaceutical companies, including the manufacturer of Rosesolute. All content is editorially independent with no conflicts of interest.